Nectar Lifescience Financials
NSE: NECLIFE | BSE: 532649
₹11.93
As on 10-Sep-2026IST
Market cap
₹231 Cr
Revenue (TTM)
₹7 Cr
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
7.44
|
--
|
--
|
1,684.09
|
1,523.67
|
1,668.83
|
|||||
|
Total Income
|
17.34
|
10.64
|
10.41
|
1,701.14
|
1,576.73
|
1,680.15
|
|||||
|
Total Expenditure
|
94.20
|
60.70
|
0.19
|
1,532.53
|
1,470.66
|
1,510.29
|
|||||
|
EBITDA
|
-86.76
|
-60.70
|
-0.19
|
151.55
|
53.01
|
158.54
|
|||||
|
Depreciation
|
0.46
|
0.34
|
0.62
|
60.72
|
59.12
|
56.97
|
|||||
|
EBIT
|
-87.22
|
-61.05
|
-0.81
|
90.84
|
-6.11
|
101.57
|
|||||
|
Interest
|
36.28
|
37.48
|
8.53
|
89.62
|
89.37
|
78.81
|
|||||
|
Other Income
|
9.90
|
10.64
|
10.41
|
17.06
|
53.06
|
11.32
|
|||||
|
Exceptional Items
|
88.15
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-25.46
|
-87.88
|
1.07
|
18.27
|
-42.42
|
34.08
|
|||||
|
Provision for Tax
|
-39.82
|
-30.53
|
0.38
|
13.27
|
-18.24
|
9.03
|
|||||
|
Profit after Tax
|
14.36
|
-57.35
|
0.70
|
5.00
|
-24.18
|
25.05
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
-245.06
|
-292.89
|
-113.68
|
5.00
|
-24.18
|
25.05
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
582.30
|
582.30
|
956.11
|
1,069.25
|
1,064.59
|
1,087.91
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
13.26
|
-215.28
|
14.54
|
141.51
|
213.12
|
296.29
|
|||||
|
Current Liabilities
|
26.05
|
26.05
|
1,021.54
|
972.82
|
890.93
|
1,003.83
|
|||||
|
Total Liabilities
|
621.61
|
621.61
|
2,047.22
|
2,191.06
|
2,189.21
|
2,390.83
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
329.30
|
108.31
|
754.60
|
899.75
|
937.46
|
1,033.18
|
|||||
|
Current Assets
|
252.97
|
252.97
|
1,237.59
|
1,283.83
|
1,231.18
|
1,354.85
|
|||||
|
Total Assets
|
621.61
|
621.61
|
2,047.22
|
2,191.06
|
2,189.21
|
2,390.83
|
|||||
|
Total Debt*
|
--
|
--
|
582.02
|
635.54
|
753.83
|
859.93
|
|||||
|
Net Current Assets
|
226.92
|
226.92
|
216.05
|
311.02
|
340.26
|
351.02
|
|||||
|
Contingent Liabilities
|
--
|
229.52
|
101.95
|
198.18
|
161.45
|
75.65
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-348.72
|
169.44
|
224.69
|
133.65
|
95.01
|
|||||
|
Cash Flow from Investing Activities
|
--
|
1,208.15
|
-41.93
|
-17.03
|
51.70
|
16.64
|
|||||
|
Cash from Financing Activities
|
--
|
-766.51
|
-128.09
|
-205.44
|
-185.58
|
-119.38
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
92.91
|
-0.58
|
2.23
|
-0.23
|
-7.73
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-0.72
|
-15.08
|
-5.07
|
0.22
|
-1.08
|
1.12
|
|||||
|
Cash EPS (₹)
|
-12.61
|
-2.93
|
0.06
|
2.93
|
1.56
|
3.66
|
|||||
|
Adjusted Book Value (₹)
|
29.17
|
29.98
|
42.63
|
47.68
|
47.47
|
48.51
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
-17.95
|
7.56
|
10.02
|
5.96
|
4.24
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
8.19
|
9.42
|
4.69
|
3.69
|
-0.33
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-4.75
|
0.59
|
6.12
|
2.49
|
5.77
|
|||||
|
ROE (%)
|
-1.21
|
-7.46
|
0.07
|
0.47
|
-2.25
|
2.33
|
|||||
|
ROA (%)
|
1.08
|
-4.80
|
0.03
|
0.23
|
-1.06
|
1.05
|
|||||
|
EBIT Margin (%)
|
-1,171.85
|
--
|
--
|
5.39
|
-0.40
|
6.09
|
|||||
|
Net Margin (%)
|
82.84
|
-538.87
|
6.70
|
0.29
|
-1.53
|
1.49
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
3.41
|
2.00
|
4.26
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
29.44
|
--
|
-100.00
|
10.53
|
-8.70
|
8.13
|
|||||
|
EBIT Growth (%)
|
-5,157.44
|
-7,473.82
|
-100.89
|
1,586.17
|
-106.02
|
146.53
|
|||||
|
Net Profit Growth (%)
|
-46,139.07
|
-8,327.69
|
-86.05
|
120.66
|
-196.55
|
134.19
|
|||||
|
EPS Growth (%)
|
-43.39
|
-197.43
|
-2,376.25
|
120.65
|
-196.54
|
134.19
|
|||||
|
Book Value Growth (%)
|
--
|
-39.10
|
-10.58
|
0.44
|
-2.14
|
2.44
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-16.87
|
--
|
--
|
135.18
|
--
|
21.53
|
|||||
|
Price / Book Value
|
0.41
|
0.31
|
0.54
|
0.63
|
0.33
|
0.50
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-1.55
|
-1.37
|
105.53
|
7.66
|
10.30
|
8.13
|
|||||
|
Close Price (₹)
|
11.57
|
9.30
|
22.95
|
30.15
|
15.95
|
24.05
|
|||||
|
High Price (₹)
|
23.87
|
28.27
|
56.50
|
45.70
|
34.20
|
48.40
|
|||||
|
Low Price (₹)
|
9.20
|
9.30
|
21.85
|
14.36
|
14.36
|
18.55
|
|||||
|
Market Cap (₹ Cr)
|
231.36
|
--
|
--
|
675.32
|
355.62
|
539.37
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
0.61
|
0.59
|
0.71
|
0.79
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
0.46
|
0.39
|
0.43
|
0.46
|
|||||
|
Current Ratio
|
9.71
|
9.71
|
1.21
|
1.32
|
1.38
|
1.35
|
|||||
|
Quick Ratio
|
9.70
|
9.70
|
0.54
|
0.59
|
0.63
|
0.69
|
|||||
|
Interest Coverage
|
0.30
|
-1.34
|
1.13
|
1.20
|
0.53
|
1.43
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
22.52
|
18.35
|
26.78
|
|||||
|
Asset Turnover
|
0.01
|
--
|
--
|
0.89
|
0.77
|
0.81
|
|||||
|
Receivable days
|
--
|
--
|
--
|
62.43
|
75.92
|
77.89
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
130.94
|
139.23
|
118.26
|
|||||
|
Payable days
|
--
|
--
|
--
|
112.09
|
109.47
|
107.25
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
81.28
|
105.68
|
88.90
|